PBMs and health insurers decide what medicines you can get, and they set the price you pay at the pharmacy. At the same time, over half of every dollar spent on medicines goes to these middlemen and others. Find out more: https://lnkd.in/e2eY5jCz
PhRMA
Pharmaceutical Manufacturing
Washington, District of Columbia 57,831 followers
Research. Progress. Hope.
About us
Our Mission: The Pharmaceutical Research & Manufacturers of America (PhRMA) has as its mission to conduct effective advocacy for public policies that encourage discovery of important new medicines for patients by pharmaceutical and biotechnology research companies. To accomplish this mission, PhRMA is dedicated to achieving these goals in Washington, the states and the world: Broad patient access to safe and effective medicines through a free market, without price controls; Strong intellectual property incentives; And transparent, effective regulation and a free flow of information to patients. Who We Are: The Pharmaceutical Research and Manufacturers of America (PhRMA) represents innovative biopharmaceutical research and discovery companies. PhRMA is devoted to advancing public policies in the U.S. and around the world that support innovative medical research, yield progress for patients today and provide hope for the treatments and cures of tomorrow. Key Facts about the Biopharmaceutical Industry: - Since 2000, PhRMA member companies have invested more than $900 billion in the search for new treatments and cures. - America’s biopharmaceutical industry is the global leader in medical innovation, with more than 500 new medicines approved by the Food and Drug Administration since 2000. - The biopharmaceutical pipeline has over 7,000 new medicines currently in development around the world. Get fresh content daily by subscribing to our updates at https://catalyst.phrma.org/subscribe
- Website
-
https://www.PhRMA.org
External link for PhRMA
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Washington, District of Columbia
- Type
- Nonprofit
- Founded
- 1958
- Specialties
- Policy, Scientific Research, Advocacy, Public Affairs, Federal Affairs, State Government Affairs, and pharmaceuticals
Locations
-
Primary
670 Maine Ave SW
Washington, District of Columbia 20024, US
Employees at PhRMA
Updates
-
PhRMA, the National Medical Association and the National Health Council recently debuted the U.S. Consensus Framework on Health Equity and Ethics in Lima, Peru. Learn more about the framework here:
In our new blog post, PhRMA, the National Medical Association, and the National Health Council jointly wrote about our experience in Lima, Peru and the unveiling of the U.S. Consensus Framework on Health Equity. Check it out!
-
"With the complexity of the science and the speed of innovation, no one player has all the answers.” Takeda Oncology’s Pallavi Garg discusses the value of industry partnerships in helping patients live more productive lives in a recent discussion with Lori Reilly about oncology innovation. By working together, manufacturers are achieving new and promising scientific breakthroughs that address unmet needs and transform the patient journey. Watch the full conversation here: https://lnkd.in/enVrcQJW
-
Congratulations to PhRMA’s General Counsel James Stansel for being named to this year’s #PharmaVoice100, which recognizes the most inspiring people in the life sciences industry.
Every day, my team and I use our experience in health care law to help increase patient access to innovative treatment and cures. It’s an honor to be recognized for that work by the Pharma Voice 100 list. This may be an individual award, but the accomplishments cited by @PharmaVoice are really a team effort. https://lnkd.in/eC8wFpnM
The 2024 PharmaVoice 100
pharmavoice.com
-
Eli Lilly and Company and Co CEO Dave Ricks shares how the Inflation Reduction Act’s unintended consequences are impacting innovation in cancer. #BreastCancerAwarenessMonth
-
Did you know that 42% of Americans have two or more chronic diseases? Get the latest on new breakthrough treatments to prevent these chronic illnesses in our report: https://lnkd.in/eEapWCeg
-
“I worry that legislation is going to change the number of new medicines that will be brought forward for later line and more rare cancers.” Canaan General Partner Julie Grant advocates for policies that promote the development of new and promising treatments for rare cancers. #RareCancerDay
-
Our CEO Stephen Ubl advocates for lowering costs for patients by holding pharmacy benefit managers accountable and improving the 340B program.
-
Attendees of our Virtual STEM Career Expo will have the opportunity to connect with talent recruiters from biopharmaceutical leaders including Bristol Myers Squibb, Eli Lilly and Company, Genentech, Gilead Sciences, GSK, Lundbeck, Merck, Otsuka Pharmaceutical Companies (U.S.), Pfizer, and Takeda. Join us to explore STEM career opportunities that support scientific advances addressing our global health challenges. Register for free today: https://lnkd.in/gjRuqqAc
Register for our Virtual STEM Career Expo
-
#OTD the #HatchWaxmanAct celebrates 40 years of success in helping bring lower costs generics to market for patients across the country. Unfortunately, too often access to generics is blocked by insures and PBMs to drive up profits. Read more on our blog:
40 Years of Hatch-Waxman: How Can We Secure its Legacy?
phrma.org